copanlisib

Ligand id: 7875

Name: copanlisib

Structure and Physico-chemical Properties

2D Structure
Calculated Physico-chemical Properties
Hydrogen bond acceptors 10
Hydrogen bond donors 2
Rotatable bonds 9
Topological polar surface area 127.43
Molecular weight 480.22
XLogP 0.22
No. Lipinski's rules broken 0

Molecular properties generated using the CDK

Classification
Compound class Synthetic organic
Approved drug? Yes (FDA (2017))
IUPAC Name
2-amino-N-[7-methoxy-8-(3-morpholin-4-ylpropoxy)-2,3-dihydroimidazo[1,2-c]quinazolin-5-yl]pyrimidine-5-carboxamide
International Nonproprietary Names
INN number INN
9726 copanlisib
Synonyms
Aliqopa® | BAY 80-6946 | BAY80-6946
Database Links
CAS Registry No. 1032568-63-0
ChEMBL Ligand CHEMBL3218576
GtoPdb PubChem SID 223366204
PubChem CID 24989044
RCSB PDB Ligand 6E2
Search Google for chemical match using the InChIKey PZBCKZWLPGJMAO-UHFFFAOYSA-N
Search Google for chemicals with the same backbone PZBCKZWLPGJMAO
Search PubMed clinical trials copanlisib
Search PubMed titles copanlisib
Search PubMed titles/abstracts copanlisib
Search UniChem for chemical match using the InChIKey PZBCKZWLPGJMAO-UHFFFAOYSA-N
Search UniChem for chemicals with the same backbone PZBCKZWLPGJMAO
Wikipedia Copanlisib
Comments
Copanlisib is a phosphoinositide 3-kinase (PI3K) inhibitor [1], preferentially inhibiting PI3Kα and PI3Kβ, and with significant antineoplastic activity [2]. The compound has no significant mTOR activity.